50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
NASDAQ:BTX

Brooklyn ImmunoTherapeutics - BTX Earnings Date, Estimates & Call Transcripts

$0.24
-0.01 (-3.93%)
(As of 09/29/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.24
▼
$0.26
50-Day Range
$0.22
▼
$0.58
52-Week Range
$0.21
▼
$10.10
Volume
294,755 shs
Average Volume
510,065 shs
Market Capitalization
$14.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00

Earnings Summary

Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

BTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BTX Earnings Date and Information

Brooklyn ImmunoTherapeutics last announced its earnings data on July 1st, 2022. The reported ($0.17) EPS for the quarter. Brooklyn ImmunoTherapeutics has generated ($2.27) earnings per share over the last year (($2.27) diluted earnings per share). Brooklyn ImmunoTherapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, October 3rd, 2022 based off prior year's report dates.

Brooklyn ImmunoTherapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
10/3/2022
(Estimated)		        
7/1/2022Q1 2022($0.17)($0.17)($0.17)
7/1/2022Q1 2022($0.17)($0.17)($0.17)
7/1/2022Q1 2022($0.17)($0.17)($0.17)
4/15/2022Q4 2021($0.16)($0.16)($0.16)
4/15/2022Q4 2021($0.16)($0.16)($0.16)
4/15/2022Q4 2021($0.16)($0.16)($0.16)
11/9/2021Q3 2021($0.11)($0.11)$1.48
11/9/2021Q3 2021($0.11)($0.11)$1.48
11/8/20219/30/2021($0.08)($0.11)($0.03)$1.48
8/16/2021Q2 2021($0.24)($0.24)($0.24)
8/16/2021Q2 2021($0.24)($0.24)($0.24)
8/16/2021Q2 2021($0.24)($0.24)($0.24)
3/11/2021Q4 2020$0.22+$0.22$0.22$1.18 million
3/11/2021Q4 2020$0.22+$0.22$0.22$1.18 million
3/11/2021Q4 2020$0.22+$0.22$0.22$1.18 million
11/13/2020Q3 2020($1.00)($1.00)($1.00)$1.48 million
11/13/2020Q3 2020($1.00)($1.00)($1.00)$1.48 million
11/13/2020Q3 2020($1.00)($1.00)($1.00)$1.48 million
8/7/2020Q2 2020($1.32)($1.32)($1.26)$0.75 million
8/7/2020Q2 2020($1.32)($1.32)($1.26)$0.75 million
8/7/2020Q2 2020($1.32)($1.32)($1.26)$0.75 million
5/19/2020Q1 2020($0.28)($0.28)$0.28$2.39 million
5/19/2020Q1 2020($0.28)($0.28)$0.28$2.39 million
5/19/2020Q1 2020($0.28)($0.28)$0.28$2.39 million
3/17/2020Q4 2019($0.56)($0.56)($0.22)$5.17 million
3/17/2020Q4 2019($0.56)($0.56)($0.22)$5.17 million
3/17/2020Q4 2019($0.56)($0.56)($0.22)$5.17 million
10/30/2019Q3 2019($0.24)($0.24)($0.24)$4.58 million
10/30/2019Q3 2019($0.24)($0.24)($0.24)$4.58 million
10/30/2019Q3 2019($0.24)($0.24)($0.24)$4.58 million
8/9/2019Q2 2019($0.06)($0.06)($0.06)$5.23 million
8/9/2019Q2 2019($0.06)($0.06)($0.06)$5.23 million
8/8/2019Q2 2019($0.05)($0.06)($0.01)$0.08$1.04 million$0.78 million  
5/13/2019Q1 2019($0.22)($0.22)($0.22)$4.83 million
5/9/2019Q1 2019($0.06)$0.30+$0.36$0.30$0.66 million$0.93 million
5/9/20193/31/2019($0.06)$0.30+$0.36$0.30$0.66 million$0.93 million  
3/20/2019Q4 2018$0.30$0.22($0.08)$0.40$6.93 million$5.92 million
3/14/2019Q4 2018($0.07)($0.07)$0.21$0.74 million$0.76 million
3/14/201912/31/2018($0.07)($0.07)$0.21$0.74 million$0.76 million  
11/8/2018Q3 2018($0.06)($0.07)($0.01)($0.67)$0.75 million$0.98 million
11/8/2018Q3($0.06)($0.07)($0.01)($0.67)$0.75 million$0.98 million
11/7/2018Q3 2018($0.08)$0.16+$0.24$0.16$5.92 million$6.00 million
8/2/2018Q2 2018($0.46)($0.10)+$0.36($0.10)$5.73 million$5.65 million
8/2/2018Q2 2018($0.09)($0.06)+$0.03($0.09)$0.33 million$2.55 million
8/2/2018Q2 2018($0.09)($0.06)+$0.03($0.09)$0.33 million$2.55 million
5/10/2018Q1 2018($0.08)($0.09)($0.01)$0.32$0.83 million$0.70 million
5/10/2018Q1 2018($0.08)($0.09)($0.01)$0.32$0.83 million$0.70 million
5/9/2018Q1 2018($0.54)($0.32)+$0.22($0.32)$5.36 million$5.76 million
3/15/2018Q4 2017($0.06)($0.08)($0.02)$0.42$2.38 million$1.00 million
3/15/2018Q4 2017($0.06)($0.08)($0.02)$0.42$2.38 million$1.00 million
3/6/2018Q4 2017($0.28)($0.50)($0.22)($0.50)$5.50 million$5.30 million
3/6/2018Q4 2017($0.28)($0.50)($0.22)($0.50)$5.50 million$5.30 million
3/6/2018Q4 2017($0.28)($0.50)($0.22)($0.50)$5.50 million$5.30 million
11/9/2017Q3 2017($0.09)($0.05)+$0.04($0.22)$1.69 million
11/7/2017Q3 2017($0.42)($0.14)+$0.28($0.14)$5.64 million$5.20 million
11/7/2017Q3 2017($0.42)($0.14)+$0.28($0.14)$1.69 million
8/2/2017Q2 2017($0.70)($0.14)+$0.56($0.14)$5.74 million$5.55 million
8/2/2017Q2 2017($0.09)($0.05)+$0.04$0.01$0.38 million
8/2/2017Q2 2017($0.09)($0.05)+$0.04$0.01$0.38 million
5/10/2017Q1 2017($0.09)($0.08)+$0.01($0.62)$0.39 million
5/10/2017Q1 2017($0.09)($0.08)+$0.01($0.62)$0.39 million
5/3/2017Q1 2017($0.78)($0.08)+$0.70($0.08)$5.52 million$5.23 million
3/6/2017Q4 2016($0.38)($0.44)($0.06)($0.44)$6.00 million$5.98 million
3/6/2017Q4 2016($0.38)($0.44)($0.06)($0.44)$6.00 million$5.98 million
3/6/2017Q4 2016($0.38)($0.44)($0.06)($0.44)$6.00 million$5.98 million
11/8/2016Q3 2016($0.96)($0.62)+$0.34($0.62)$5.54 million$5.44 million
11/3/2016Q3 2016($0.20)($0.08)+$0.12($0.46)$1.46 million$1.50 million
11/3/2016Q316($0.14)($0.08)+$0.06($0.46)$1.46 million$1.50 million
8/9/2016Q2 2016($0.17)($0.11)+$0.06($0.48)$2.15 million$1.27 million
8/9/2016Q216($0.17)($0.11)+$0.06($0.48)$1.75 million$1.27 million
8/3/2016Q2 2016($1.00)($0.92)+$0.08($0.92)$5.65 million$5.41 million
5/10/2016Q1 2016($0.12)($0.19)($0.07)($0.19)$1.36 million$2.07 million
5/10/2016Q116($0.14)($0.19)($0.05)($0.19)$1.43 million$2.10 million
5/6/2016Q1 2016($2.00)($1.00)+$1.00($1.00)$5.90 million$5.48 million
3/15/2016Q4 2015($0.16)($0.16)($0.16)$1.31 million
3/15/2016Q4($0.17)($0.16)+$0.01($0.16)$1.31 million
3/11/2016Q4 2015($1.00)($1.00)($1.00)$6.60 million$6.52 million
11/9/2015Q3 2015($0.18)($0.18)($0.18)$2.31 million
11/9/2015Q3 2015($0.18)($0.18)($0.18)$2.31 million
11/5/2015Q3 2015($2.00)($1.00)+$1.00($1.00)$6.20 million$6.08 million
8/10/2015Q2 2015($0.12)($0.12)($0.12)$2.01 million
8/10/2015Q2($0.12)($0.12)($0.12)$2.01 million
8/6/2015Q2 2015($3.00)($3.00)($3.00)$5.60 million$6.19 million
5/11/2015Q1 2015($0.13)($0.13)($0.13)$1.26 million
5/11/2015Q115($0.13)($0.13)($0.13)$1.10 million$1.30 million
5/7/2015Q1 2015($2.00)($2.00)($2.00)$5.73 million
3/26/2015Q4 2014($2.00)($2.00)($2.00)$6.75 million
3/26/2015Q4 2014($2.00)($2.00)($2.00)$6.75 million
3/26/2015Q4 2014($2.00)($2.00)($2.00)$6.75 million
3/11/2015Q4 2014($0.14)($0.14)($0.14)$1.89 million
3/11/2015Q4 2014($0.14)($0.14)($0.14)$1.89 million
11/10/2014Q3 2014($0.12)($0.12)($0.12)$1.19 million
11/10/2014Q314($0.12)($0.12)($0.12)$1.20 million
11/6/2014Q3 2014($1.00)($1.00)($1.00)$6.01 million
8/13/2014Q2 2014($1.00)($1.00)$6.87 million
8/12/2014Q2 2014($0.16)($0.16)($0.16)$1.11 million
8/12/2014Q214($0.16)($0.16)($0.16)$362.25 million$300.08 million
5/14/2014Q1 2014($1.00)($1.00)($1.00)$6.42 million
5/12/2014Q1 2014($0.14)($0.14)($0.14)$1.07 million
5/12/2014Q114($0.14)($0.14)($0.14)$0.61 million$1.07 million  
3/17/2014Q4 2013($0.35)($0.35)($0.35)$1.89 million
3/17/2014Q4 2013($0.35)($0.35)($0.35)$1.89 million
11/12/2013Q3 2013($0.16)($0.16)($0.16)$0.71 million
11/12/2013Q3 2013($0.16)($0.16)($0.16)$0.71 million
8/9/2013Q2 2013($0.14)($0.14)($0.14)$1.22 million
8/9/2013Q2 2013($0.14)($0.14)($0.14)$1.22 million
5/10/2013Q1 2013($0.15)($0.15)($0.15)$0.61 million
5/10/2013Q1 2013($0.15)($0.15)($0.15)$0.61 million
5/9/2013Q1 2013($1.00)($1.00)($1.00)$6.12 million
3/18/2013Q412($0.12)($0.12)$1.70 million$1.20 million
11/9/2012Q3 2012($0.10)($0.10)($0.10)
8/9/2012Q2 2012($0.11)($0.11)($0.11)
5/10/2012Q1 2012($0.10)($0.10)($0.10)
3/14/2012Q4 2011($0.10)($0.10)($0.10)
11/8/2011Q3 2011($0.08)($0.08)($0.08)
8/9/2011Q2 2011($0.09)($0.09)($0.09)
5/5/2011Q1 2011($0.07)($0.07)($0.07)
3/15/2011Q4 2010($0.06)($0.06)($0.06)
11/15/2010Q3 2010($0.06)($0.06)($0.01)
8/16/2010Q2 2010($0.06)($0.06)($0.06)
5/5/2010Q1 2010($0.04)($0.04)($0.04)
3/10/2010Q4 2009$0.06+$0.06$0.06
11/24/2009Q3 2009($0.11)($0.11)($0.11)
3/30/2009Q4 2008($0.07)($0.07)($0.07)
5/19/2008Q1 2008($0.02)($0.02)($0.02)
4/15/2008Q4 2007($0.01)($0.01)($0.01)












Brooklyn ImmunoTherapeutics Earnings - Frequently Asked Questions

When is Brooklyn ImmunoTherapeutics's earnings date?

Brooklyn ImmunoTherapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, October 3rd, 2022 based off last year's report dates. Learn more on BTX's earnings history.

How much revenue does Brooklyn ImmunoTherapeutics generate each year?

Brooklyn ImmunoTherapeutics (NASDAQ:BTX) has a recorded annual revenue of $5.80 million.

How much profit does Brooklyn ImmunoTherapeutics generate each year?

Brooklyn ImmunoTherapeutics (NASDAQ:BTX) has a recorded net income of -$122.54 million. BTX has generated -$2.27 earnings per share over the last four quarters.

More Earnings Resources from MarketBeat

Earnings Tools:
Earnings By Country:
Latest Articles:
Upcoming Earnings:
This page (NASDAQ:BTX) was last updated on 9/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.